Literature DB >> 24355864

Myeloperoxidase directs properdin-mediated complement activation.

Joseph O'Flynn1, Karen O Dixon, Maria C Faber Krol, Mohamed R Daha, Cees van Kooten.   

Abstract

Neutrophils and complement are key members of innate immunity. The alternative pathway (AP) of complement consists of C3, factor B, factor D and properdin, which amplifies AP activation. AP has been implicated in many neutrophil-mediated diseases, such as anti-neutrophil cytoplasmic antibody-associated vasculitis. The exact mechanism by which the AP and neutrophils interact remains largely unstudied. We investigated the ability of the AP to interact with neutrophil components which can be exposed and released upon activation. Our studies focused on neutrophil enzymes, including myeloperoxidase (MPO), proteinase 3 (PR3), azurocidin, elastase, lysozyme and cathepsin G. All enzymes except for azurocidin were able to bind properdin. However, only MPO could induce C3 activation. MPO mediated AP complement activation in the presence of MgEGTA compared to the EDTA control. This activation resulted in C3 deposition and required properdin to occur. Furthermore, we could show that MPO binds properdin directly, which then serves as a focus for AP activation. In summary, properdin can directly interact with neutrophil components. MPO demonstrates the ability to activate the AP which is dependent on properdin. Finally, MPO is capable of inducing properdin-initiated C3 and C5b-9 deposition in vitro.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24355864      PMCID: PMC6741500          DOI: 10.1159/000356980

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  24 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.

Authors:  P Venge; I Olsson
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

3.  Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes.

Authors:  M Botto; D Lissandrini; C Sorio; M J Walport
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

4.  The role of properdin in the assembly of the alternative pathway C3 convertases of complement.

Authors:  Dennis E Hourcade
Journal:  J Biol Chem       Date:  2005-11-21       Impact factor: 5.157

5.  Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation.

Authors:  M B Pepys; A E Butterworth
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

6.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 7.  Properdin: emerging roles of a pattern-recognition molecule.

Authors:  Claudia Kemper; John P Atkinson; Dennis E Hourcade
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Shen-Ju Gou; Jun Yuan; Min Chen; Feng Yu; Ming-Hui Zhao
Journal:  Kidney Int       Date:  2012-08-22       Impact factor: 10.612

9.  Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils.

Authors:  M Shingu; S Nonaka; H Nishimukai; M Nobunaga; H Kitamura; K Tomo-Oka
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis.

Authors:  P Hewins; M D Morgan; N Holden; D Neil; J M Williams; C O S Savage; L Harper
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

View more
  19 in total

1.  Properdin binding to complement activating surfaces depends on initial C3b deposition.

Authors:  Morten Harboe; Christina Johnson; Stig Nymo; Karin Ekholt; Camilla Schjalm; Julie K Lindstad; Anne Pharo; Bernt Christian Hellerud; Kristina Nilsson Ekdahl; Tom Eirik Mollnes; Per H Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

2.  NETosis, complement, and coagulation: a triangular relationship.

Authors:  Cynthia M de Bont; Wilbert C Boelens; Ger J M Pruijn
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

3.  Neutrophil extracellular traps can activate alternative complement pathways.

Authors:  H Wang; C Wang; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2015-06-22       Impact factor: 4.330

Review 4.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

Review 5.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

Review 6.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

Review 7.  Properdin: a tightly regulated critical inflammatory modulator.

Authors:  Adam Z Blatt; Sabina Pathan; Viviana P Ferreira
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

8.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways.

Authors:  Joshua Yuen; Fred G Pluthero; David N Douda; Magdalena Riedl; Ahmed Cherry; Marina Ulanova; Walter H A Kahr; Nades Palaniyar; Christoph Licht
Journal:  Front Immunol       Date:  2016-04-14       Impact factor: 7.561

10.  Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5.

Authors:  Simon J Freeley; Reena J Popat; Kiran Parmar; Martin Kolev; Beverley J Hunt; Cordula M Stover; Willhelm Schwaeble; Claudia Kemper; Michael G Robson
Journal:  J Pathol       Date:  2016-09       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.